Literature DB >> 23083027

Synthetic cannabinoid-induced psychosis: two adolescent cases.

Olumide O Oluwabusi, Liudmila Lobach, Umair Akhtar, Branden Youngman, Paul J Ambrosini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23083027     DOI： 10.1089/cap.2012.0004

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN： 1044-5463            Impact factor:   2.576


× No keyword cloud information.
  13 in total

1.  Novel psychoactive substances of interest for psychiatry.

Authors:  Fabrizio Schifano; Laura Orsolini; G Duccio Papanti; John M Corkery
Journal:  World Psychiatry       Date:  2015-02       Impact factor: 49.548

Review 2.  Synthetic Pot: Not Your Grandfather's Marijuana.

Authors:  Benjamin M Ford; Sherrica Tai; William E Fantegrossi; Paul L Prather
Journal:  Trends Pharmacol Sci       Date:  2017-02-02       Impact factor: 14.819

Review 3.  The Bridge Between Classical and "Synthetic"/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective.

Authors:  Laura Orsolini; Stefania Chiappini; Duccio Papanti; Domenico De Berardis; John M Corkery; Fabrizio Schifano
Journal:  Front Psychiatry       Date:  2019-11-20       Impact factor: 4.157

Review 4.  Spicing things up: synthetic cannabinoids.

Authors:  Max Spaderna; Peter H Addy; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2013-07-09       Impact factor: 4.530

5.  The effects of synthetic cannabinoids on executive function.

Authors:  K Cohen; M Kapitány-Fövény; Y Mama; M Arieli; P Rosca; Z Demetrovics; A Weinstein
Journal:  Psychopharmacology (Berl)       Date:  2017-02-03       Impact factor: 4.530

6.  Linking in vitro and ex vivo CB1 activity with serum concentrations and clinical features in 5F-MDMB-PICA users to better understand SCRAs and their metabolites.

Authors:  Liesl K Janssens; Simon Hudson; David M Wood; Caitlin Wolfe; Paul I Dargan; Christophe P Stove
Journal:  Arch Toxicol       Date:  2022-08-12       Impact factor: 6.168

7.  A preliminary evaluation of synthetic cannabinoid use among adolescent cannabis users: Characteristics and treatment outcomes.

Authors:  Claire E Blevins; Kelsey E Banes; Robert S Stephens; Denise D Walker; Roger A Roffman
Journal:  Addict Behav       Date:  2016-07-08       Impact factor: 3.913

8.  Clinical Effects of Synthetic Cannabinoid Receptor Agonists Compared with Marijuana in Emergency Department Patients with Acute Drug Overdose.

Authors:  Milana Zaurova; Robert S Hoffman; David Vlahov; Alex F Manini
Journal:  J Med Toxicol       Date:  2016-06-02

Review 9.  Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal.

Authors:  Ziva D Cooper
Journal:  Curr Psychiatry Rep       Date:  2016-05       Impact factor: 5.285

Review 10.  Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems.

Authors:  William E Fantegrossi; Catheryn D Wilson; Michael D Berquist
Journal:  Drug Metab Rev       Date:  2018-01-31       Impact factor: 4.518
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.